Valuation: Grifols, S.A.

Capitalization 5.55B 6.41B 5.09B 4.79B 8.92B 610B 9.06B 60.51B 23.55B 295B 24.06B 23.53B 1,027B P/E ratio 2026 *
11.9x
P/E ratio 2027 * 8.93x
Enterprise value 13.95B 16.11B 12.8B 12.04B 22.43B 1,535B 22.78B 152B 59.2B 742B 60.47B 59.16B 2,581B EV / Sales 2026 *
1.82x
EV / Sales 2027 * 1.67x
Free-Float
79.23%
Yield 2026 *
2.82%
Yield 2027 * 3.26%
1 day+0.04%
1 week-2.39%
Current month-2.39%
1 month-0.18%
3 months-9.96%
6 months-15.74%
Current year-15.35%
1 week 8.9
Extreme 8.902
9.45
1 month 8.62
Extreme 8.62
9.84
Current year 8.43
Extreme 8.432
11.7
1 year 8.43
Extreme 8.432
13.7
3 years 6.36
Extreme 6.362
15.92
5 years 6.36
Extreme 6.362
25.94
10 years 6.36
Extreme 6.362
34.31
Manager TitleAgeSince
Chief Executive Officer 57 2024-03-31
Director of Finance/CFO 49 2024-09-15
Compliance Officer 54 2013-12-31
Director TitleAgeSince
Director/Board Member 69 2024-12-07
Director/Board Member 70 2024-12-07
Chairman 76 2010-01-24
Date Insider Type Main position Quantity % Market Cap.
02-25Free

Director

7,679 0.0018%
02-25Free

Director

1,408 0.0005%
02-17Others

Director

1,408 0.0003%
Change 5d. change 1-year change 3-years change Capi.($)
+0.04%-2.39%-12.06%-23.37% 6.41B
+1.07%+3.36%+28.84%-15.06% 64.65B
+0.58%+3.69%+60.37%+210.79% 57.37B
-0.74%+34.00%+34.00%+34.00% 39.87B
+5.75%+1.35%-59.53%-68.18% 33.6B
-0.57%-0.34%+46.73%-34.84% 28.84B
+1.13%+5.83%+48.87%+65.91% 20.45B
-8.04%+0.53%+72.76%-62.62% 18.82B
+0.26%-8.10%+4.72%+109.86% 16.99B
+0.27%+1.00%+45.38%+107.72% 16.35B
Average -0.02%+0.12%+27.01%+32.42% 30.34B
Weighted average by Cap. +0.43%+1.15%+30.15%+42.28%

Financials

2026 *2027 *
Net sales 7.68B 8.87B 7.05B 6.63B 12.35B 845B 12.54B 83.76B 32.6B 409B 33.3B 32.57B 1,421B 8.18B 9.45B 7.51B 7.06B 13.15B 900B 13.36B 89.22B 34.72B 435B 35.47B 34.7B 1,514B
Net income 510M 589M 468M 440M 820M 56.1B 833M 5.56B 2.16B 27.13B 2.21B 2.16B 94.34B 690M 796M 633M 595M 1.11B 75.88B 1.13B 7.52B 2.93B 36.69B 2.99B 2.92B 128B
Net Debt 8.4B 9.7B 7.71B 7.25B 13.51B 924B 13.72B 91.61B 35.65B 447B 36.42B 35.63B 1,554B 8.08B 9.33B 7.41B 6.97B 12.99B 889B 13.19B 88.1B 34.29B 430B 35.02B 34.26B 1,495B
Logo Grifols, S.A.
Grifols, S.A. specializes in the research, development, manufacturing and marketing of therapeutic products and medical devices for use in hospitals and medical analysis laboratories. Net sales break down by family of products and services as follows: - products derived from plasma (86.2%): products for use by the pharmaceutical and biotechnology industries; - diagnostic machines and reagents (8.5%): in vitro hemophilic diagnostic equipment, coagulation analyzers, infectious serology reagents, etc. for use primarily by blood banks and transfusion centers; - hospital products (2.1%): non-biological surgical products, radiology and nutritional products, etc. for use by hospital pharmacies; - other (3.2%): primarily intermediate biological products and subcontracted manufacturing services. Net sales are distributed geographically as follows: Spain (5.6%), European Union (15.9%), the United States and Canada (56.5%) and other (22%).
Employees
25,000
Date Price Change Volume
26-06-05 9.058 +0.04% 1,799,694
26-06-04 9.054 +0.94% 2,926,782
26-06-03 8.970 -1.43% 2,233,983
26-06-02 9.100 -1.17% 1,582,176
26-06-01 9.208 -0.78% 1,824,623
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
9.058EUR
Average target price
14.58EUR
Spread / Average Target
+61.00%

Quarterly revenue - Rate of surprise